美國漢美馳-迴流破壁全營養調理機(K)
- 品號：3877025
結果上網搜尋後 美國漢美馳-迴流破壁全營養調理機(K) ,在momo購物網上看到這 美國漢美馳-迴流破壁全營養調理機(K) 果然又有優惠而且又有折價券，
互相比較之下真的比在各大賣場場,還要便宜在momo購物網上可馬上宅配到家， 美國漢美馳-迴流破壁全營養調理機(K) 安全性高又有不怕被騙，
現在網購充滿著許多詐騙新聞真的要很小心！
為了買一樣東西這些天到處,逛了許多的大賣場和商店,直到找到 美國漢美馳-迴流破壁全營養調理機(K) 好東西,
覺得比較過後 美國漢美馳-迴流破壁全營養調理機(K) 還是有些猶豫,想想不如到購物網站上,找一找有沒有在做促銷,
如果又有優惠折價券可以使用,應該是最划算的了,
商品組合：
調理機(含 容杯、上蓋)*1
相關配件：
攪拌棒*1、食譜*1、簡易說明卡*1、說明書(含保卡)*1、乳化杯*1(裝於上蓋)、保固補充說明*1
◆型號：58911-TW
◆額定電壓/頻率：110V~/60Hz
◆消耗功率：1200W
◆規格：
(1)容杯容量：1.8公升
(2)刀片材質：不鏽鋼
(3)馬力：2.4匹
◆使用方式：請參閱說明
◆注意事項：
(1)請參閱說明
(2)使用攪拌棒時請務必蓋上杯蓋使用。
◆產地：中國
◆商檢：R63999
◆保固：總代理公司貨8年全機保固
| 保固期 | 8年保固期總代理公司貨8年全機保固 |
|---|
- 品號：3877025
最近 美國漢美馳-迴流破壁全營養調理機(K) 又有網購節及一特定節日，推薦.評價.比較 上演大特價，實在很划算
開箱文 美國漢美馳-迴流破壁全營養調理機(K) .心得文.最便宜.試用文.分享文，
- 品號：3877025
2016-11-1103:00
‘BEST IN ASIA’: The government plans to invest NT$10.94 billion in the industry next year to develop large-scale healthcare firms, new drugs and new medical devicesBy Chen Wei-han / Staff reporterThe Executive Yuan yesterday approved a multibillion-dollar project to develop the biomedical industry through a tax incentive scheme to increase innovation and export medical services to the world.The project, which is part of President Tsai Ing-wen’s （蔡英文） campaign pledge to develop the “five plus two” innovative industries, aims to relax investment and recruitment regulations to lure and retain foreign capital and talent, and to encourage local businesses to acquire international companies and develop foreign markets, Executive Yuan spokesman Hsu Kuo-yung （徐國勇） said.The government is to invest NT$10.94 billion （US$346.32 million） in the next year to develop 10 large-scale healthcare firms, 20 new drugs and 80 new medical devices to be marketed internationally by 2025 in a bid to boost the annual value of the biomedical industry to NT$1 trillion, Ministry of Science and Technology Department of Life Sciences Director-General Tsai Shaw-jenq （蔡少正） said.The ministry is to build a “biomedical corridor” connecting the nation’s science parks to maximize research capabilities, he said.“The nation’s medical service is the best in Asia and the third best in the world, and we want to export the service by completing the infrastructure of the healthcare industry,” Tsai Shaw-jenq said.The government is looking to tap into the global senior healthcare market, especially in Southeast Asia, while developing specialized medical therapies for diseases that people of Chinese ethnicity are prone to develop.The program will also exempt biomedical start-ups from taxation in the early stages after an initial public offering, while restrictions that prohibit academics from assuming positions in private companies will be lifted to encourage university spin-off companies, Minister of Science and Technology Yang Hung-duen （楊弘敦） said.The Executive Yuan also passed an amendment to the Act for the Development of Biotech and New Pharmaceuticals Industry （生技新藥產業發展條例） to provide tax incentives to companies as part of the development package.The new incentive scheme allows a 35 to 50 percent tax credit on a company’s research and development expenses and personnel training cost. Shareholders are also to receive a 20 percent tax credit on the investment amount, or the purchase price of the stock, Vice Minister of Economic Affairs Shen Jong-chin （沈榮津） said.“This is special legislation and it is the only legislation that offers a tax incentive scheme,” Shen said, adding that the act, even without the amendment, already saw investment in the biotechnology sector increase to NT$48.4 billion last year.The amendment will also lift restrictions on the development and production of high-risk medical devices and new drugs to prompt manufacturers to develop such products, as current legislation lags behind technological advancement, Shen said.The move will benefit about 50 medical instrument and 13 regenerative medicine firms in the fields of precision medicine, gene therapy and cell therapy, he added.新聞來源：TAIPEI TIMES
引用自momo購物
ECDA58269E9962BF
全站熱搜
留言列表
